Cited by 541Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysProtein Degradation and Inhibitors

The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development

Open access
Bernassola, Francesca, Karin, Michael, Ciechanover, Aaron, Melino, Gerry·2008·Cancer Cell

Abstract

The involvement of the homologous to E6-AP carboxyl terminus (HECT)-type E3s in crucial signaling pathways implicated in tumorigenesis is presently an area of intense research and extensive scientific interest. This review highlights recent discoveries on the ubiquitin-mediated degradation of crucial tumor suppressor molecules catalyzed by the HECT-type E3s. By providing a portrait of their protein targets, we intend to link the substrate specificity of HECT-type E3s with their contribution to tumorigenesis. Moreover, we discuss the relevance of targeting the HECT E3s, through the development of small-molecule inhibitors, as an anticancer therapeutic strategy.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2008.06.001

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bernassola, F., Karin, M., Ciechanover, A., & Melino, G.
Affiliations
  • University of Rome Tor Vergata (IT)
  • University of California San Diego (US)
  • Technion – Israel Institute of Technology (IL)
Corresponding author
Melino, Gerry
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2008-07
Volume
14
Issue
1
Pages
10-21
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2067343115
Cited by
541
References
3
Citations by year
2026: 5 · 2025: 15 · 2024: 18 · 2023: 36 · 2022: 22 · 2021: 43 · 2020: 30 · 2019: 31 · 2018: 26 · 2017: 32 · 2016: 34 · 2015: 40 · 2014: 45 · 2013: 32 · 2012: 39
FWCI
2.37
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Keywords
HECT E3 ubiquitin ligase, E3 ubiquitin ligase, ubiquitin-mediated proteolysis, tumor suppressor proteins, carcinogenesis, substrate specificity, small molecule inhibitors, anticancer agents
MeSH terms
Nedd4 Ubiquitin Protein Ligases, Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Enzyme Inhibitors, Humans, Neoplasms, Repressor Proteins, Substrate Specificity, Signal Transduction, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Tumor Suppressor Proteins, Ubiquitin, Ubiquitin-Protein Ligases, Endosomal Sorting Complexes Required for Transport

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review